BioSpace News Archive

Pharm Country

ŌNŌCOR Reports First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Intracardiac TumorUntil now, removal of intracardiac tumors has typically required open-heart surgery

ŌNŌCOR LLC is excited to announce the first-in-human use of the ŌNŌ endovascular retrieval system for removal of an intracardiac tumor. Intracardiac tumors affect thousands of patients around the world annually, but prior to ŌNŌ, open-heart surgery was required for removal.

August 2, 2022
·
2 min read
FDA

MAIA Biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of Small-Cell Lung Cancer (SCLC)

MAIA Biotechnology, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to THIO, a telomere-targeting agent currently in development to evaluate its activity in multiple cancer indications, for the treatment of small cell lung cancer.

August 2, 2022
·
5 min read
Pharm Country

Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum

Milestone Scientific Inc. today announced that it has commenced sales of the CompuFlo ® Epidural system to the University of Scranton for incorporation into the student registered nurse anesthesia (SRNA) program.

August 2, 2022
·
3 min read
Genetown

Agenus to Participate at BTIG Biotechnology Conference

Agenus today announced the Company will attend the BTIG Biotechnology Conference.

August 2, 2022
·
1 min read
BioMidwest

UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel

Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, is expanding on its Hygieia product line with the launch of a new premium revitalizing eye gel.

August 2, 2022
·
4 min read
Drug Development

Light E.N.T. Seeks Volunteers for ENLIGHTEN I Phase 3 Clinical Research Study in Chronic Rhinosinusitis

Light E.N.T. is seeking volunteers for Phase 3 of the ENLIGHTEN I clinical research study.

August 2, 2022
·
1 min read
Pharm Country

Peptilogics to Participate in Musculoskeletal Infection Society (MSIS) 32nd Annual Open Scientific Meeting in Pittsburgh

Peptilogics will participate in the Musculoskeletal Infection Society (MSIS) 32nd Annual Open Scientific Meeting taking place in Pittsburgh August 5-6.

August 2, 2022
·
5 min read
Biotech Bay

InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study

InterVenn® Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced the start of enrollment in its prospective cohort study for early detection of colorectal cancer and adenomas.

August 2, 2022
·
4 min read
Business

CARsgen Appoints Dr. Hua Jiang as Executive Director

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that Dr. Hua Jiang (“Dr. Jiang”) has been appointed as Executive Director of the Company.

August 2, 2022
·
3 min read
Business

CURE Pharmaceutical Announces the Appointment of New Board Member

CURE Pharmaceutical Holding Corp., a proprietary platform technology company, announced the appointment of Gerald Bagg to its board of directors.

August 2, 2022
·
5 min read